Bioactive saponins and glycosides. XV. Saponin constituents with gastroprotective effect from the seeds of tea plant, Camellia sinensis L. var. assamica Pierre, cultivated in Sri Lanka: Structures of assamsaponins A, B, C, D, and E

Chemical and Pharmaceutical Bulletin

Volumn 47, Issue 12, 1999, Pages 1759-1764

  Murakami, Toshiyuki ^a   Nakamura, Junko ^a   Matsuda, Hisashi ^a   Yoshikawa, Masayuki ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Assamsaponin; Camellia sinensis var. assamica; Gastroprotective effect; Oleanane type triterpene oligoglycoside; Tea plant

Indexed keywords

ASSAMSAPONIN A; ASSAMSAPONIN B; ASSAMSAPONIN C; ASSAMSAPONIN D; ASSAMSAPONIN E; SAPONIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; NONHUMAN; PHYSICAL CHEMISTRY; PLANT SEED; RAT; STOMACH MUCOSA LESION; STOMACH PROTECTION; STRUCTURE ACTIVITY RELATION; TEA;

EID: 0033395727     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.47.1759     Document Type: Article

References (24)

1. Part XIV: Matsuda H., Murakami T., Ikebata A., Yamahara J., Yoshikawa M., Chem. Pharm. Bull., submitted in publication (Paper No. 1815).
2. a) Yoshikawa M., Shimada H., Nishida N., Li Y., Toguchida I., Yamahara J., Matsuda H., Chem. Pharm. Bull., 46, 113-119 (1998);
3. b) Yoshikawa M., Murakami T., Yashiro K., Yamahara J., Matsuda H., Saijoh R., Tanaka O., ibid., 46, 647-654 (1998);
4. c) Yoshikawa M., Murakami T., Yamahara J., Matsuda H., ibid., 46, 1764-1769 (1998);
5. d) Matsuda H., Li Y., Murakami T., Yamahara J., Yoshikawa M., Life Sci., 63, PL245-250 (1998);
6. e) Matsuda H., Murakami T., Li Y., Yamahara J., Yoshikawa M., Bioorg. Med. Chem., 6, 1019-1023 (1998);
7. f) Matsuda H., Li Y., Murakami T., Yamahara J., Yoshikawa M., Eur. J. Pharmacol., 368, 237-243 (1999);
8. g) Matsuda H., Li Y., Yamahara J., Yoshikawa M., J. Pharmacol. Exp. Ther., 289, 729-734 (1999).
9. a) Yoshikawa M., Murakami T., Komatsu H., Yamahara J., Matsuda H., Heterocycles, 47, 397-405 (1998);
10. b) Yoshikawa M., Murakami T., Komatsu H., Matsuda H., Chem. Pharm. Bull., 46, 812-816 (1998);
11. c) Komatsu H., Murakami T., Matsuda H., Yoshikawa M., Heterocycles, 48, 703-710 (1998);
12. d) Yoshikawa M., Murakami T., Shimada H., Fukada N., Matsuda H., Sashida Y., Yamahara J., ibid., 48, 869-873 (1998);
13. e) Yoshikawa M., Murakami T., Kadoya M., Yamahara J., Matsuda H., Chem. Pharm. Bull., 46, 1758-1763 (1998);
14. f) Yoshikawa M., Murakami T., Hirano K., Matsuda H., Yamahara J., Ohtani K., Kasai R., Yamasaki K., Heterocycles, 49, 93-96 (1998);
15. g) Matsuda H., Li Y., Murakami T., Yamahara J., Yoshikawa M., Bioorg. Med. Chem., 7, 323-327 (1999);
16. h) Li Y., Matsuda H., Yoshikawa M., Bioorg. Med. Chem., 7, 1201-1205 (1999);
17. Matsuda H., Li Y., Yoshikawa M., Life Sci., 65, PL27-32 (1999).
18. Yoshikawa M., Murakami T., Yoshizumi S., Murakami N., Yamahara J., Matsuda H., Chem. Pharm. Bull., 44, 1899-1907 (1996).
19. Kitagawa I., Hori K., Motozawa T., Murakami T., Yoshikawa M., Chem. Pharm. Bull., 46, 1901-1906 (1998).
20. Murakami T., Nakamura J., Li Y., Matsuda H., Yoshikawa M., presented at the 119th Annual Meeting of the Pharmaceutical Society of Japan, Tokushima, March 1999, Abstracts of Papers Part II, p. 136.
21. Yoshikawa K., Nakagawa M., Yamamoto R., Arihara S., Matsuura K., Chem. Pharm. Bull., 40, 1779-1782 (1992).
22. Hara S., Okabe H., Mihashi K., Chem. Pharm. Bull., 34, 1843-1845 (1986).
23. 13C HOHAHA) and HMBC experiments.
24. Martin M. J., Marhuenda E., Perez-Guerrero C., Franco J. M., Pharmacology, 49, 144-150 (1994).